EyePoint Pharmaceuticals: Q1 Earnings Snapshot

WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — EyePoint Pharmaceuticals (EYPT) on Wednesday reported a loss of $29.3 million in its first quarter.

On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 55 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.

The drug delivery technology company posted revenue of $11.7 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $12.5 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EYPT at https://www.zacks.com/ap/EYPT

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up